Clinical indications for plasma protein assays: Transthyretin (prealbumin) in inflammation and malnutrition - International federation of clinical chemistry and laboratory medicine (IFCC): IFCC scientific division committee on plasma proteins (C-PP)

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 3, 2007, Pages 419-426

  Johnson, A Myron ^a,e   Merlini, Giampaolo ^b   Sheldon, Joanna ^c   Ichihara, Kiyoshi ^d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PAVIA   (Italy)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NONE   (United States)

Author keywords

Inflammation; Malnutrition; Prealbumin; Transthyretin

Indexed keywords

C REACTIVE PROTEIN; LIVER PROTEIN; PLASMA PROTEIN; PREALBUMIN; TRANSFERRIN;

ACCURACY; ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; BACTERIAL INFECTION; BLOOD CHEMISTRY; CHILD; CLINICAL CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; INFANT; INFLAMMATION; KIDNEY DISEASE; LABORATORY TEST; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALNUTRITION; MORBIDITY; MORTALITY; NEWBORN; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CALORIE MALNUTRITION; PROTEIN DETERMINATION; RETINOL DEFICIENCY; TRANSFERRIN BLOOD LEVEL; VISCERA;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PROTEINS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INFLAMMATION; MALNUTRITION; MIDDLE AGED; PREALBUMIN; REFERENCE VALUES; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS);

EID: 33947609131     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.051     Document Type: Conference Paper

References (71)

1. Fuhrman MP, Charney P, Mueller CM. Hepatic proteins and nutrition assessment. J Am Diet Assoc 2004;104:1258-64.
2. Johnson AM. Low levels of plasma proteins: malnutrition or inflammation? Clin Chem Lab Med 1999;37:91-6.
3. Shenkin A. Assessment of nutritional status - implications for nutritional support and hospitalization. Plasma Protein Monitor 2005;1:9-11.
4. Mears E. Nutritional assessment. An opportunity for laboratorians to improve health care. Clin Lab News 2005;June:12-6.
5. Brugler L, Stankovic A, Bernstein L, Scott F, O'Sullivan-Maillet J. The role of visceral protein markers in protein calorie malnutrition. Clin Chem Lab Med 2002;40:1360-9.
6. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr 1994;14:495-533.
7. Gidden F, Shenkin A. Laboratory support of the clinical nutrition service. Clin Chem Lab Med 2000;38:693-714.
8. Pencharz PB, Azcue M. Use of bioelectrical impedance analysis measurements in the clinical management of malnutrition. Am J Clin Nutr 1996;64(Suppl):485S-8S.
9. Yeh SS, Hafner A, Chang CK, Levine DM, Parker TS, Schuster MW. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. J Am Geriatr Soc 2004;52:1708-12.
10. Yovita H, Djumhana A, Abdurachman SA, Saketi JR. Correlation between anthropometric measurements, prealbumin level and transferrin serum with Child-Pugh classification in evaluating nutritional status of liver cirrhosis. Acta Med Indones 2004;35:197-201.
11. Koretz RL. Nutrition Society Symposium on "End points in clinical nutrition trials." Death, morbidity and economics are the only end points for trials. Proc Nutr Soc 2005;64:277-84.
12. Cano NJ, Pichard C, Roth H, Court-Fortune I, Cynober L, Gerard-Boncompain M, et al. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest 2004;126:540-6.
13. Ingbar SH. Pre-albumin: a thyroxin binding protein of human plasma. Endocrinology 1958;63:256-9.
14. Rask L, Anundi H, Peterson PA. The primary structure of the human retinol-binding protein. FEBS Lett 1979;104:55-8.
15. Schultze HE, Heremans JF. Molecular biology of human proteins. London: Elsevier, 1966:476-7.
16. Schultze HE, Schönenberger M, Schwick G. Über ein Präalbumin des menschlichen Serums. Biochem Z 1956; 328:267-84.
17. Goodman DS, Peters T, Robbins J, Schwick G. Prealbumin becomes transthyretin. J Biol Chem 1981;256:12-4.
18. Monaco HL. The transthyretin-retinol-binding protein complex. Biochim Biophys Acta 2000;1482:65-72.
19. Noy N, Slosberg E, Scarlata S. Interactions of retinol with binding proteins: studies with retinol binding protein and with transthyretin. Biochemistry 1992;31:11118-24.
20. Gitlin D, Pericelli A. Synthesis of serum albumin, prealbumin, alpha-fetoprotein, alpha-1-antitrypsin and transferrin by the human yolk sac. Nature 1970;228:995-7.
21. Bienvenu J, Jeppsson J-O, Ingenbleek Y. Transthyretin (prealbumin) and retinol binding protein. In: Ritchie RF, Navolotskaia O, editors. Serum proteins in clinical medicine, vol. 1. Laboratory section. Scarborough, ME: Foundation for Blood Research, 1995:9.01.01-9.01.07.
22. Jacobsson B. In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut. Histochemistry 1989;91:299-304.
23. Ong DE, Davis JT, O'Day WT, Bok D. Synthesis and secretion of retinol-binding protein and transthyretin by cultured retinal pigment epithelium. Biochemistry 1994;33:1835-42.
24. Oppenheimer JH, Surks MI, Bernstein G, Smith JC. Metabolism of iodine 131-labeled thyroxin-binding prealbumin in man. Science 1965;149:748-51.
25. Socolow EL, Woeber KA, Purdy RH, Holloway MT, Ingbar SH. Preparation of I131-labeled human serum prealbumin and its metabolism in normal and sick patients. J Clin Invest 1965;44:1600-9.
26. Wallace MR, Naylor S, Kluve-Beckerman B, Long GL, McDonald L. Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 1985;129:753-8.
27. Costa PP, Figueira A, Bravo F. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 1978;75:4449-503.
28. Nordlie M, Sletten K, Husby G, Ranlov PJ. A new prealbumin variant in familial cardiomyopathy of Danish origin. Scand J Immunol 1988;27:119-22.
29. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies wreviewx. J Intern Med 2004;255:159-78.
30. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 1999;13:273-9.
31. McClave SA, Mitoraj TE, Thielmeier KA, Greenburg RA. Differentiating subtypes (hypoalbuminemic vs marasmic) of protein-calorie malnutrition: incidence and clinical significance in a university hospital setting. J Parenter Enteral Nutr 1992;16:337-42.
32. Manary MJ, Broadhead RL, Yarasheski KE. Whole-body protein kinetics in marasmus and kwashiorkor during acute infection. Am J Clin Nutr 1998;67:1205-9.
33. Iputo JE. Protein-losing enteropathy in Transkeian children with morbid protein-energy malnutrition. S Afr Med J 1993;83:588-9.
34. Peters T Jr. Serum albumin. Adv Protein Chem 1985; 37:161-245.
35. Ingenbleek Y, De Visscher M, De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet 1972;2:106-9.
36. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitamin A deficiency: meta-analysis. Lancet 2003;362:2052-8.
37. Vellas B, Guigoz Y, Baumgartner M, Garry PJ, Lauque S, Albarede J-L. Relationships between nutritional markers and the mini-nutritional assessment in 155 older persons. J Am Geriatr Soc 2000;48:1300-9.
38. Raynaud-Simon A, Lafont S, Berr C, Dartigues JF, Baulieu EE, Le Bouc Y. Plasma insulin-like growth factor I levels in the elderly: relation to plasma dehydroepiandrosterone sulfate levels, nutritional status, health and mortality. Gerontology 2001;47:198-206.
39. Whicher JT. Acute phase proteins: diagnostic significance and clinical use. AACC Endo 1993;11:273-80.
40. Banks RE, Forbes MA, Storr M, Higginson J, Thompson D, Raynes J, et al. The acute phase protein response in patients receiving subcutaneous IL-6. Clin Exp Immunol 1995;102:217-23.
41. Clark MA, Hentzen BT, Plank LD, Hill GI. Sequential changes in insulin-like growth factor 1, plasma proteins, and total body protein in severe sepsis and multiple injury. J Parenter Enteral Nutr 1996;20:363-70.
42. Spies M, Wolf SE, Barrow RE, Jeschke MG, Herndon DN. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 2002;30:83-98.
43. Pepersack T. Outcomes of continuous process improvement of nutritional care program among geriatric units. J Gerontol A Biol Sci Med Sci 2005;60:787-92.
44. Reimund JM, Arondel Y, Escalin G, Finck G, Baumann R, Duclos B. Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis 2005;37:424-31.
45. Ferard G, Gaudias J, Bourguignat A, Ingenbleek Y. Creactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med 2002;40:1334-8.
46. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res 1985;55:91-101.
47. Bellinghieri G, Santoro D, Calvani M, Savica V. Role of carnitine in modulating acute-phase protein synthesis in hemodialysis patients. J Renal Nutr 2005;15:13-7.
48. Thompson D, Whicher JT, Banks RE. Acute phase proteins in predicting disease outcome. Baillières Clin Rheumatol 1992;6:393-404.
49. Kaysen GA. Effects of inflammation on plasma composition and endothelial structure and function. J Renal Nutr 2005;15:94-8.
50. Rannevik G, Carstrom K, Doeberl A, Laurell C-B. Plasma protein changes induced by two orally administered androgen derivatives. Scand J Clin Lab Invest 1996;56:161-6.
51. Barbe P, Bennet A, Stebenet M, Perret B, Louvet JP. Sex-hormone-binding globulin and protein-energy malnutrition indexes as indicators of nutritional status in women with anorexia nervosa. Am J Clin Nutr 1993;57:319-22.
52. Nova E, Lopez-Vidriero I, Varela P, Toro O, Casas JJ, Marcos AA. Indicators of nutritional status in restricting-type anorexia nervosa patients: a 1-year follow-up study. Clin Nutr 2004;23:1353-9.
53. Raguso CA, Genton L, Dupertuis YM, Pichard C. Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator? Clin Chem Lab Med 2002;40:1325-8.
54. Smale BF, Mullen JL, Hobbs CL, Buzby GP, Rosato EF. Serum protein response to acute dietary manipulation. J Surg Res 1980;28:379-88.
55. Smale BF, Hobbs CL, Mullen JL, Rosato EF. Serum protein response to surgery and starvation. J Parenter Enteral Nutr 1982;6:395-8.
56. Van Wymelbeke V, Guedon A, Maniere D, Manckoundia P, Pfitzenmeyer P. A 6-month follow-up of nutritional status in institutionalized patients with Alzheimer's disease. J Nutr Health Aging 2004;8:505-8.
57. Goodman DS. Plasma retinol-binding protein. In: Sporn MB, Roberts AB, Goodman DS, editors. The retinoids, vol. 2. New York: Academic Press, 1984:41-88.
58. Kopple JD, Mehrotra R, Suppasyndh O, Kalantar-Zadeh K. Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure. Clin Chem Lab Med 2002;40:1308-12.
59. Scarpioni L, Dall'Agio PP, Poisetti PG, Buzio C. Retinol binding protein in serum and urine of glomerular and tubular nephropathies. Clin Chim Acta 1976;68:107-13.
60. Visvardis G, Griveas I, Fleva A, Giannakou A, Papadopoulou D, Mitsopoulos E, et al. Relevance of procalcitonin levels in comparison to other markers of inflammation in hemodialysis patients. Renal Fail 2005;27:429-34.
61. Gower T. Nutritional screening tools for CAPD patients: are computers the way forward? EDTNA ERCA J 2001; 27:197-200.
62. Kaysen GA, Kumar V. Inflammation in ESRD: causes and potential consequences. J Renal Nutr 2003;13:158-60.
63. Gerard G, Gaudias J, Bourguignat A, Ingenbleek Y. Creactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection. Clin Chem Lab Med 2002;40:1334-8.
64. Lim SH, Lee JS, Chae SH, Ahn BS, Chang DJ, Shin CS. Prealbumin is not sensitive indicator of nutrition and prognosis in critical ill patients. Yonsei Med J 2005;46:21-6.
65. Sullivan DH, Bopp MM, Roberson PK. Protein-energy undernutrition and life-threatening complications among the hospitalized elderly. J Gen Intern Med 2002; 17:923-32.
66. Pascal N, Amouzou EK, Sanni A, Namour F, Abdelmouttaleb I, Vidailhet M, et al. Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus. Am J Clin Nutr 2002;76:239-44.
67. Sandstedt S, Cederblad G, Larsson J, Schildt B, Symreng T. Influence of total parenteral nutrition on plasma fibronectin in malnourished subjects with or without inflammatory response. J Parenter Enteral Nutr 1984;8:493-6.
68. Fieber SS. Pseudocholinesterase - a clinical assessment. Crit Care Med 1981;9:660-1.
69. Crowe PJ, Snyman AM, Dent DM, Bunn AE. Assessing malnutrition in gastric carcinoma: bioelectrical impedance or clinical impression? Aust NZ J Surg 1992;62:390-3.
70. Baudner S, Bienvenu J, Blirup-Jensen S, Carlström A, Johnson AM, Ward AM, et al. The certification of a matrix reference material for immunochemical measurement of 14 human serum proteins. Publication 92/92. Brussels: BCR, 1992.
71. Blirup-Jensen S, Johnson AM, Larsen M. Protein standardization IV: value transfer procedure for the assignment of serum protein values from a reference preparation to a target material. Clin Chem Lab Med 2001;38:1110-22.